Search results

|IUPACName=4-(2-aminoethyl)benzene-1,2-diol |OtherNames=2-(3,4-dihydroxyphenyl)ethylamine;<br/> 3,4-dihydroxyphenethylamine;<br/> 3-h

| CASNo = 10024-97-2 | InChI = InChI=1/N2O/c1-2-3

| IUPAC_name = (R*,S*)-2-(methylamino)-1-phenylpropan-1-ol | InChI = 1/C10H15NO/c1-8(11-2)10(12)9-6-4-3-5-7-9/h3-8,10-12H,1-2H3/t8-,10-/m0/s1

| page = 2 }}</ref>, NMT and DMT in leaf (1.1-10.2 ppm)<ref>[http://www.cababstractsplus.org/google/abstract.asp?AcNo=20053115 Document Title: Animal Feed Science and Technology, 2005 (Vol. 121) (No. 1/2) 175-190</ref> [[Image:Acacia angustissima usgs.png|thumb|left|80px]]

| list7 = [[Amphetamine]]{{·}} [[Befuraline]]{{·}} [[Lisdexamfetamine]]{{·}} [[Methamphetamine]] | group3 = <small>[[Voltage-dependent calcium channel|α2δ-VDCC]] [[Calcium channel blocker|blocker]]s</small>

...[[Psi-2C-T-4]] • [[TCB-2]]<br/>''Stimulants:'' [[2-Hydroxyphenethylamine|2-OH-PEA]] • [[β-Methylphenethylamine|β-Me-PEA]] • [[Hordenine]] • [[ | group2 = [[Substituted_amphetamine|Amphetamine]]s<br />'''''<small>[[Phenylisopropylamine]]s<small>'''''

[[1-(4-Methylphenyl)-2-aminobutane]] • [[2-Fluoroamphetamine]] •

...mine]] • [[Amfepentorex]] • [[Amidephrine]] • [[Amphechloral]] • [[Amphetamine]] ([[Dextroamphetamine]], [[Levoamphetamine]]) • [[Amphetaminil]] • [[A | list7 = [[4-Bromo-2,5-dimethoxy-benzylpiperazine|2C-B-BZP]] • [[Benzylpiperazine|BZP]] • [[

| group2 = [[α2-adrenergic receptor|α₂]] ...pirone]] (via metabolite [[Pyrimidinylpiperazine|1-PP]]) antagonize α₂-adrenergic receptors as well.</small>

...|5-''N'',''N''-TMT]]{{•w}} [[5-AcO-DMT]]{{•w}} [[5-MeO-2,N,N-TMT|5-MeO-2,''N'',''N''-TMT]]{{•w}} [[5-MeO-4,N,N-TMT|5-MeO-4,''N'',''N''-TMT]]{{•w ...emorphan); <br/>'''Others:''' [[3-amino-2-methyl-1,1-di(phenyl)propan-1-ol|2-MDP]]{{•w}} [[8a-Phenyldecahydroquinoline|8A-PDHQ]]{{•w}} [[Aptiganel]]

...diethylamide|LSD]]{{•}} [[Pergolide]]; ''Dihydrexidine derivatives'': [[2-OH-NPA]]{{•}} [[A-86,929]]{{•}} [[Ciladopa]]{{•}} [[Dihydrexidine]]{{ ...}} [[Butaclamol]]{{•}} [[Ecopipam]]{{•}} [[N-Ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline|EEDQ]]{{•}} [[Eticlopride]]{{•}} [[Fananserin]]{{•}}

| IUPAC_name = ''N''-(1-methyl-2-phenylethyl)-3,3-diphenylpropan-1-amine | synonyms = ''N''-(3,3-diphenylpropyl)amphetamine

| C=10 | H=11 | N=1 | O=2 ...ght these effects are mediated via a [[partial agonist]] action at [[Alpha-2 adrenergic receptor]]s, and TDIQ has been suggested as a possible drug for

...ement in acute neurologic disorders |journal=Neurol Clin |volume=26 |issue=2 |pages=585–603, xi |year=2008 |month=May |pmid=18514828 |doi=10.1016/j.nc ...ement in acute neurologic disorders |journal=Neurol Clin |volume=26 |issue=2 |pages=585–603, xi |year=2008 |month=May |pmid=18514828 |doi=10.1016/j.nc

...nstriction results from the increased concentration of [[calcium]] (Ca²⁺ [[ions]]) within vascular [[smooth muscle cells]].<ref>{{cite journa Examples include [[amphetamine]]s, [[antihistamine]]s and [[cocaine]]. Many are used in medicine to treat

...***Before you make any edits, MAKE SURE YOU (1) cite reliable sources and (2) adhere to Wikipedia's "Manual of Style". Any improperly added or inappropr ...url=http://www.sciencedirect.com/science?_ob=ArticleURL&_udi=B6T8D-4K7WC0F-2&_user=10&_coverDate=12%2F06%2F2006&_rdoc=17&_fmt=summary&_orig=browse&_srch

...te journal | journal=J Subst Abuse Treat | year =1991 | volume=8 | issue=1-2 | pages=19–28 | title=Protracted withdrawal syndromes from benzodiazepine ...tion, such as prolonged psychosis or [[major depression|depression]] after amphetamine or cocaine abuse. A [[protracted withdrawal syndrome]] can also occur with

.../ref> a potent [[Kappa Opioid receptor|κ-opioid]] and [[D2 receptor|D₂ receptor]] [[agonist]].<ref name="Zhang2005pabs" /><ref name="Seeman2 ...ism.<ref name="Marushia2002p2">[[#refMarushia2002|Marushia 2002]], p.&nbsp;2.</ref> He later documented its usage and reported its effects through perso